Pipeline Progress at Regeneron - Zacks.com

Pipeline Progress at Regeneron - Zacks.com: "

Pipeline Progress at Regeneron Zacks.com DME refers to a disease of the retina that affects individuals suffering from diabetes and can lead to blindness. Positive results of VEGF trap-eye from a phase II study in DME patients (announced late last year) encouraged the partners to move the ... Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic ...PR Newswire (press release) Bayer, Regeneron Start Phase III Trial Of VEGF Trap-EyeNASDAQ Regeneron Begins Phase 3 Study Of New Eye Solution In Diabetic Macular EdemaRTT News Pharma Times all 40 news articles »

"